Initiative in LYon for Lung cAncer Screening Development - Prevalence Study

CompletedOBSERVATIONAL
Enrollment

4,595

Participants

Timeline

Start Date

October 31, 2020

Primary Completion Date

January 14, 2021

Study Completion Date

January 14, 2021

Conditions
Lung CancerScreening
Interventions
OTHER

Survey

The objective is to evaluate the eligibility of the responders, as defined by NELSON criteria and PLCOm2012 scoring, and their willingness to participate to a lung-cancer screening with low-dose computed tomography.

Trial Locations (1)

69000

Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04240418 - Initiative in LYon for Lung cAncer Screening Development - Prevalence Study | Biotech Hunter | Biotech Hunter